Direct immunofluorescence in the diagnosis of scleroderma syndromes.

Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis (1985) 1.20

The use of immunofluorescent techniques in dermatology. Ulster Med J (1978) 0.75

Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12

Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66

Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26

The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19

The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17

Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis. Arch Dermatol (1967) 2.15

Herpes simplex infections in hematologic malignancies. Am J Med (1972) 2.13

Kaposi's sarcoma: a clinicopathologic study with particular reference to its relationship to the reticuloendothelial system. Medicine (Baltimore) (1965) 2.04

Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol (1989) 1.84

Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83

Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients. Mayo Clin Proc (1968) 1.67

A quantitative study of Meissner's corpuscles in man. Neurology (1966) 1.55

Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol (1996) 1.54

Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) (1968) 1.50

Vasculitis and retinoids. Lancet (1989) 1.49

Necrotizing vasculitis and atherosclerosis. Br J Dermatol (1988) 1.49

Evidence for eosinophil degranulation with deposition of granule major basic protein in solar urticaria. J Am Acad Dermatol (1989) 1.48

Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol (1977) 1.48

Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma: a reappraisal of 30 cases formerly classified as well differentiated liposarcoma. Cancer (1979) 1.47

Histiocytic cytophagic panniculitis. J Am Acad Dermatol (1989) 1.46

Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985. Mayo Clin Proc (1990) 1.42

Fatal systemic cytophagic histiocytic panniculitis: a histopathologic and immunohistochemical study of multiple organ sites. J Am Acad Dermatol (1994) 1.39

Cancer and scleroderma. Arch Dermatol (1979) 1.39

Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39

Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38

Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant. J Am Acad Dermatol (1988) 1.38

Ophthalmic features of necrobiotic xanthogranuloma with paraproteinemia. Am J Ophthalmol (1984) 1.37

Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol (1996) 1.35

Generalized plane xanthoma and systemic disease. Arch Dermatol (1966) 1.34

Histopathologic findings in anetoderma. Arch Dermatol (1984) 1.34

The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33

Erythroderma with atypical lymphocytes. (Sézary syndrome). Am J Med (1973) 1.33

Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32

Quantitative studies on the Langerhans cell population of guinea pig epidermis. J Invest Dermatol (1967) 1.31

Prostaglandins and chemotaxis: enhancement of polymorphonuclear leukocyte chemotaxis by prostaglandin F2alpha. J Invest Dermatol (1976) 1.30

Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol (1980) 1.28

Papulonecrotic tuberculid: a neglected disease in Western countries. J Am Acad Dermatol (1986) 1.27

Bullous pyoderma gangrenosum and leukemia. Arch Dermatol (1972) 1.27

Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26

Necrobiotic xanthogranuloma. Arch Dermatol (1992) 1.25

Dermatofibrosarcoma protuberans. Study of fifty-six cases. Am J Surg (1966) 1.24

The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24

Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases. Medicine (Baltimore) (1986) 1.24

Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol (1998) 1.24

Panniculitis in connective tissue disease. Arch Dermatol (1983) 1.23

Esophageal deterioration in scleroderma. Mayo Clin Proc (1971) 1.23

The Merkel cell. J Invest Dermatol (1973) 1.22

Ultrastructural localization of nucleoside triphosphatase in Langerhans cells. J Invest Dermatol (1967) 1.22

Necrotising vasculitis associated with lethal reticuloendothelial diseases. Br J Dermatol (1968) 1.21

Necrobiotic xanthogranuloma. Australas J Dermatol (1980) 1.21

Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol (1988) 1.20

The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20

The skin in histiocytosis X. Mayo Clin Proc (1969) 1.20

Panniculitis and systemic lupus erythematosus. JAMA (1970) 1.19

Cutaneous periarteritis nodosa. Arch Dermatol (1974) 1.19

Classification and pathogenesis of scleroderma. Mayo Clin Proc (1971) 1.19

Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18

The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17

Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15

Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15

T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15

Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14

Generalized eruptive histiocytoma. Enzyme histochemistry and electron microscopy. Arch Dermatol (1967) 1.14

The histopathology of localized lipoatrophy. Br J Dermatol (1986) 1.13

Nerve endings in the human lumbar spinal column and related structures. J Bone Joint Surg Am (1966) 1.12

Ulcerative lichen planus of the feet. Bullous variant with hair and nail lesions. Arch Dermatol (1966) 1.12

Anetoderma. Clinical findings, associations, and long-term follow-up evaluations. Arch Dermatol (1984) 1.12

Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11

Erythema elevatum diutinum: a clinicopathological study. Clin Exp Dermatol (1992) 1.11

Disabling pansclerotic morphea of children. Arch Dermatol (1980) 1.11

Quantitation of Meissner's corpuscles in hereditary neurologic disorders. Charcot-Marie-Tooth disease, Roussy-Levy syndrome, Dejerine-Sottas disease, hereditary sensory neuropathy, spinocerebellar degenerations, and hereditary spastic paraplegia. Neurology (1966) 1.10

Histopathology of the skin in dermatomyositis. A histopathologic study of 55 cases. Arch Dermatol (1968) 1.10

The disappearance and regeneration of Langerhans cells following epidermal injury. J Invest Dermatol (1968) 1.10

Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med (1980) 1.09

Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch Dermatol (1966) 1.09

Pathogenesis and staging of scleroderma. Acta Derm Venereol (1976) 1.08

Cutaneous histiocytosis X. The presence of S-100 protein and its use in diagnosis. Arch Dermatol (1983) 1.08

Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol (1970) 1.07

Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07

Nevus comedonicus with epidermolytic hyperkeratosis. A report of four cases. Arch Dermatol (1981) 1.07

Cutaneous syndromes of non-X histiocytosis. A review of the macrophage-histiocyte diseases of the skin. Arch Dermatol (1981) 1.07

Localized lipoatrophy (atrophic connective tissue disease panniculitis). Arch Dermatol (1980) 1.06

Generalized granuloma annulare. Arch Dermatol (1969) 1.05

Subcutaneous sarcoidosis. Arch Dermatol (1984) 1.04

The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases. J Am Acad Dermatol (1982) 1.04

Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04

Weber-Christian panniculitis: a review of 30 cases with this diagnosis. J Am Acad Dermatol (1998) 1.04

Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol (1980) 1.03

Serologic alterations in scleroderma and sclerodermatomyositis. Mayo Clin Proc (1971) 1.03

The cutaneous extravascular necrotizing granuloma (Churg-Strauss granuloma) and systemic disease: a review of 27 cases. Medicine (Baltimore) (1983) 1.02

Granuloma annulare: direct immunofluorescence study. Br J Dermatol (1976) 1.02

Infantile lichenoid acrodermatitis. Report of a case of Gianotti-Crosti syndrome. Arch Dermatol (1965) 1.02

Demodex granuloma. Arch Dermatol (1979) 1.02

Immunofluorescence of epithelial skin tumors. I. Patterns of intercellular substance. Cancer (1970) 1.02

Cutaneous vascular calcification, gangrene and hyperparathyroidism. Br J Dermatol (1970) 1.02

Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol (1991) 1.02